Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study von Rimini, Margherita, Shimose, Shigeo, Lonardi, Sara, Tada, Toshifumi, Masi, Gianluca, Iwamoto, Hideki, Lai, Eleonora, Burgio, Valentina, Hiraoka, Atsushi, Ishikawa, Toru, Soldà, Caterina, Shirono, Tomotake, Vivaldi, Caterina, Takaguchi, Koichi, Shimada, Noritomo, Astara, Giorgio, Koga, Hironori, Nouso, Kazuhiro, Joko, Kouji, Torimura, Takuji, Hiasa, Yoichi, Salani, Francesca, Scartozzi, Mario, Cascinu, Stefano, Casadei‐Gardini, Andrea

Volltext

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study von Fulgenzi, Claudia Angela Maria, Cheon, Jaekyung, D'Alessio, Antonio, Nishida, Naoshi, Ang, Celina, Marron, Thomas U., Wu, Linda, Saeed, Anwaar, Wietharn, Brooke, Cammarota, Antonella, Pressiani, Tiziana, Personeni, Nicola, Pinter, Matthias, Scheiner, Bernhard, Balcar, Lorenz, Napolitano, Andrea, Huang, Yi-Hsiang, Phen, Samuel, Naqash, Abdul Rafeh, Vivaldi, Caterina, Salani, Francesca, Masi, Gianluca, Bettinger, Dominik, Vogel, Arndt, Schönlein, Martin, von Felden, Johann, Schulze, Kornelius, Wege, Henning, Galle, Peter R., Kudo, Masatoshi, Rimassa, Lorenza, Singal, Amit G., Sharma, Rohini, Cortellini, Alessio, Gaillard, Vincent E., Chon, Hong Jae, Pinato, David James

Volltext

Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis von Casadei‐Gardini, Andrea, Scartozzi, Mario, Tada, Toshifumi, Yoo, Changhoon, Shimose, Shigeo, Masi, Gianluca, Lonardi, Sara, Frassineti, Luca Giovanni, Nicola, Silvestris, Piscaglia, Fabio, Kumada, Takashi, Kim, Hyung‐Don, Koga, Hironori, Vivaldi, Caterina, Soldà, Caterina, Hiraoka, Atsushi, Bang, Yeonghak, Atsukawa, Masanori, Torimura, Takuji, Tsuj, Kunihiko, Itobayashi, Ei, Toyoda, Hidenori, Fukunishi, Shinya, Rimassa, Lorenza, Rimini, Margherita, Cascinu, Stefano, Cucchetti, Alessandro, Nakamura, Shinichiro, Michitaka, Kojiro, Itokawa, Norio, Hayama, Korenobu, Hirooka, Masashi, Koizumi, Yohei, Hiasa, Yoichi, Ishikawa, Toru, Imai, Michitaka, Takaguchi, Koichi, Tsutsui, Akemi, Nagano, Takuya, Kariyama, Kazuya, Nouso, Kazuhiro, Tajiri, Kazuto, Shimada, Noritomo, Shibata, Hiroshi, Ochi, Hironori, Joko, Kouji, Yasuda, Satoshi, Ohama, Hideko, Kawata, Kazuhito

Volltext

FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer von Vivaldi, Caterina, Fornaro, Lorenzo, Vasile, Enrico, Malka, David, Castan, Florence, Conroy, Thierry

Volltext

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib von Caputo, Francesco, Dadduzio, Vincenzo, Tovoli, Francesco, Bertolini, Giulia, Cabibbo, Giuseppe, Cerma, Krisida, Vivaldi, Caterina, Faloppi, Luca, Rizzato, Mario Domenico, Piscaglia, Fabio, Celsa, Ciro, Fornaro, Lorenzo, Marisi, Giorgia, Conti, Fabio, Silvestris, Nicola, Silletta, Marianna, Lonardi, Sara, Granito, Alessandro, Stornello, Caterina, Massa, Valentina, Astara, Giorgio, Delcuratolo, Sabina, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea

Volltext

Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres von Depalo, Tommaso, Traino, Antonio Claudio, Bargellini, Irene, Lorenzoni, Giulia, Bozzi, Elena, Vivaldi, Caterina, Lamastra, Rocco, Masi, Gianluca, Cioni, Roberto, Boni, Giuseppe, Volterrani, Duccio

Volltext

Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel von Vivaldi, Caterina, Crucitta, Stefania, Catanese, Silvia, Cucchiara, Federico, Arrigoni, Elena, Pecora, Irene, Rofi, Eleonora, Fornaro, Lorenzo, Salani, Francesca, Massa, Valentina, Vasile, Enrico, Morganti, Riccardo, Danesi, Romano, Del Re, Marzia

Volltext

Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study von Bargellini, Irene, Mosconi, Cristina, Pizzi, Giuseppe, Lorenzoni, Giulia, Vivaldi, Caterina, Cappelli, Alberta, Vallati, Giulio E., Boni, Giuseppe, Cappelli, Federico, Paladini, Andrea, Sciuto, Rosa, Masi, Gianluca, Golfieri, Rita, Cioni, Roberto

Volltext

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer von Del Re, Marzia, Vivaldi, Caterina, Rofi, Eleonora, Vasile, Enrico, Miccoli, Mario, Caparello, Chiara, d’Arienzo, Paolo Davide, Fornaro, Lorenzo, Falcone, Alfredo, Danesi, Romano

Volltext

Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to act... von Fornaro, Lorenzo, Lonardi, Sara, Catanese, Silvia, Nappo, Floriana, Pietrantonio, Filippo, Pellino, Antonio, Angerilli, Valentina, Signorini, Francesca, Salani, Francesca, Murgioni, Sabina, Neculaescu, Ioana Ancuta, Bruno, Rossella, Vivaldi, Caterina, Ricagno, Gianmarco, Masi, Gianluca, Bergamo, Francesca, Ugolini, Clara, Fassan, Matteo

Volltext

About the Recently Published Paper on JAMA Oncology “Radioembolization Plus Chemotherapy for First-Line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Cli... von Bargellini, Irene, Vivaldi, Caterina, Crocetti, Laura, Masi, Gianluca

Volltext

The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer von Salati, Massimiliano, Filippi, Roberto, Vivaldi, Caterina, Caputo, Francesco, Leone, Francesco, Salani, Francesca, Cerma, Krisida, Aglietta, Massimo, Fornaro, Lorenzo, Sperti, Elisa, Di Maio, Massimo, Ortega, Cinzia, Fenocchio, Elisabetta, Lombardi, Pasquale, Cagnazzo, Celeste, Depetris, Ilaria, Gelsomino, Fabio, Spallanzani, Andrea, Santini, Daniele, Silvestris, Nicola, Aprile, Giuseppe, Roviello, Giandomenico, Scartozzi, Mario, Cascinu, Stefano, Casadei‐Gardini, Andrea

Volltext

Immune Checkpoint Inhibitors in Esophageal Cancers: are we Finally Finding the Right Path in the Mist? von Vivaldi, Caterina, Catanese, Silvia, Massa, Valentina, Pecora, Irene, Salani, Francesca, Santi, Stefano, Lencioni, Monica, Vasile, Enrico, Falcone, Alfredo, Fornaro, Lorenzo

Volltext

Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis von Casadei-Gardini, Andrea, Rimassa, Lorenza, Rimini, Margherita, Yoo, Changhoon, Ryoo, Baek-Yeol, Lonardi, Sara, Masi, Gianluca, Kim, Hyung-Don, Vivaldi, Caterina, Ryu, Min-Hee, Rizzato, Mario Domenico, Salani, Francesca, Bang, Yeonghak, Pellino, Antonio, Catanese, Silvia, Burgio, Valentina, Cascinu, Stefano, Cucchetti, Alessandro

Volltext

Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation von Fornaro, Lorenzo, Vivaldi, Caterina, Lin, Dong, Xue, Hui, Falcone, Alfredo, Wang, Yuzhuo, Crea, Francesco, Bootman, Martin D

Volltext

Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab von Ruzzo, Annamaria, Graziano, Francesco, Bagaloni, Irene, Di Bartolomeo, Maria, Prisciandaro, Michele, Aprile, Giuseppe, Ongaro, Elena, Vincenzi, Bruno, Perrone, Giuseppe, Santini, Daniele, Fornaro, Lorenzo, Vivaldi, Caterina, Tomasello, Gianluca, Loupakis, Fotios, Lonardi, Sara, Fassan, Matteo, Valmasoni, Michele, Sarti, Donatella, Lorenzini, Paola, Catalano, Vincenzo, Bisonni, Renato, Del Prete, Michela, Collina, Guido, Magnani, Mauro

Volltext

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer von Fornaro, Lorenzo, Vivaldi, Caterina, Parnofiello, Annamaria, Ugolini, Clara, Aprile, Giuseppe, De Maglio, Giovanna, Pecora, Irene, Iacono, Donatella, Crivelli, Francesca, Catanese, Silvia, Cardellino, Giovanni Gerardo, Lencioni, Monica, Vasile, Enrico, Salani, Francesca, Clerico, Mario, Calvetti, Lorenzo, Falcone, Alfredo, Fasola, Gianpiero, Fontanini, Gabriella, Montagnani, Francesco

Volltext

Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib von Casadei-Gardini, Andrea, Rovesti, Giulia, Dadduzio, Vincenzo, Vivaldi, Caterina, Lai, Eleonora, Lonardi, Sara, Fornaro, Lorenzo, Pretta, Andrea, Zagonel, Vittorina, Bernardini, Laura, Astara, Giorgio, D'Amico, Francesco E., Masi, Gianluca, Rimini, Margherita, Scartozzi, Mario, Cascinu, Stefano

Volltext

Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution von Cesario, Silvia, Genovesi, Virginia, Salani, Francesca, Vasile, Enrico, Fornaro, Lorenzo, Vivaldi, Caterina, Masi, Gianluca

Volltext

Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis von Bang, Yeonghak, Yoo, Changhoon, Lonardi, Sara, Kim, Hyung-Don, Vivaldi, Caterina, Rimini, Margherita, Frassineti, Giovanni Luca, Park, Sook Ryun, Rizzato, Mario Domenico, Ryu, Min-Hee, Salani, Francesca, Rapposelli, Ilario Giovanni, Ryoo, Baek-Yeol, Zagonel, Vittorina, Massa, Valentina, Valgiusti, Martina, Burgio, Valentina, Scartozzi, Mario, Cascinu, Stefano, Casadei-Gardini, Andrea

Volltext